(Q46898761)

26 December 2017

title

Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome (English)

1 reference

26 December 2017

polycystic ovary syndrome

main subject

1 reference

1 reference

S A R Doi

1 reference

26 December 2017

M Al-Zaid

1 reference

26 December 2017

P A Towers

1 reference

26 December 2017

C J Scott

1 reference

26 December 2017

K A S Al-Shoumer

1 reference

26 December 2017

publication date

1 November 2005

1 reference

26 December 2017

Journal of Endocrinological Investigation

published in

1 reference

26 December 2017

volume

1 reference

26 December 2017

issue

1 reference

26 December 2017

page(s)

882-892

1 reference

26 December 2017

Adult polycystic ovary syndrome begins in childhood

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Can polycystic ovary syndrome exist without concomitant hypothalamic dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

21 January 2018

Hypothalamic dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Dependence of mean levels of circulating luteinizing hormone upon pulsatile amplitude and frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

The polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Do hyperandrogenic women with normal menses have polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Polycystic ovaries in Hirsute women with normal menses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Gonadotropin evaluation in the diagnosis of polycystic ovary syndrome using either a monoclonal or a polyclonal antibody radioimmunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Correct homeostasis model assessment (HOMA) evaluation uses the computer program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Unexpected responses of the hypothalamic gonadotropin-releasing hormone "pulse generator" to physiological estradiol inputs in the absence of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

The effects of the aromatase inhibitor delta 1-testolactone on gonadotropin release and steroid metabolism in polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

The Effects of Continuous Androgen Secretion on the Hypothalamic-Pituitary Axis in Woman: Evidence from a Luteinized Thecoma of the Ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Detection of LH release from individual pituitary cells by the reverse hemolytic plaque assay: estrogen increases the fraction of gonadotropes responding to GnRH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. II. Effects of varying concentrations of estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Different responses of insulin, C-peptide, and testosterone to an oral glucose tolerance test in two groups of women with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Gonadotropin levels in women with polycystic ovary syndrome: their relationship to body weight and insulin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Irregular cycles and steroid hormones in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Increased Luteinizing Hormone Secretion in Women with Polycystic Ovary Syndrome Is Unaltered by Prolonged Insulin Infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Insulin-sensitising agents in polycystic-ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Should patients with polycystic ovarian syndrome be treated with metformin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Effect of Acute Physiological Elevations of Insulin on Circulating Androgen Levels in Nonobese Women*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345319

Insulin resistance in nonobese patients with polycystic ovary syndrome

21 January 2018

1 reference

12 December 2020

Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorion

1 reference

12 December 2020

Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndrome

1 reference

12 December 2020

Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome

1 reference

12 December 2020

Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics

1 reference

12 December 2020

Regulation of the preovulatory gonadotropin surge by endogenous steroids

1 reference

12 December 2020

Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone

1 reference

12 December 2020

Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations.

1 reference

12 December 2020

A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism

1 reference

12 December 2020

Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome1

1 reference

12 December 2020

The influence of luteinizing hormone and insulin on sex steroids and sex hormone-binding globulin in the polycystic ovarian syndrome

1 reference

12 December 2020

Idiopathic hirsutism or polycystic ovary syndrome?

1 reference

12 December 2020

Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries

1 reference

12 December 2020

Inappropriate Gonadotropin Secretion in Polycystic Ovary Syndrome: Influence of Adiposity1

1 reference

12 December 2020

Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin.

1 reference

12 December 2020

Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism

1 reference

12 December 2020

Hormonal effects of flutamide in young women with polycystic ovary syndrome

1 reference

12 December 2020

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

12 December 2020

The effect of flutamide on pulsatile gonadotrophin secretion in hyperandrogenaemic women

1 reference

12 December 2020

Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features

1 reference

12 December 2020

A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).

1 reference

12 December 2020

Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia

1 reference

12 December 2020

Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome

1 reference

12 December 2020

LH levels in women with polycystic ovarian syndrome: have modern assays made them irrelevant?

1 reference

12 December 2020

Repeatability characteristics of simple indices of insulin resistance: implications for research applications

1 reference

12 December 2020

Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity

1 reference

12 December 2020

[Do androgens modulate luteinizing hormone secretion in women?]

1 reference

12 December 2020

Insulin sensitivity and its measurement: structural commonalities among the methods

1 reference

12 December 2020

Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity

1 reference

12 December 2020

Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345319

1 reference

26 December 2017

release_6p77n75i5veirpy3uczn4qlkua

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6p77n75i5veirpy3uczn4qlkua

24 November 2022

mapped directly with Wikidata item

1 reference

26 December 2017